万孚卡蒂斯是由国内POCT行业领跑者的万孚生物（股票代码：300482）与欧洲领先的分子诊断生物技术企业比利时Biocartis在香港成立的合资公司的全资子公司。

双方共同推动全自动分子诊断平台Idylla^™（中国商标品牌为“弈景^™”）在中国大陆肿瘤精准治疗领域的商业化应用，该平台将致力于提供精确、灵敏、便捷的诊断及用药指导。万孚卡蒂斯是国内首次把全自动一体化分子诊断理念引入肿瘤精准医疗领域的公司，开创国内先河。

弈景^™是基于实时荧光PCR技术的全自动化系统，该系统整合了从样本处理到结果分析的全过程，能提供准确可靠的分子病理诊断结果，全过程仅需约2小时，手动操作时间不超过2分钟。弈景^™卓越的易用性和防污染设计，用户使用更省心，更加贴近患者。弈景^™系统支持多种生物标本类型，检测靶点多、结果准确可靠。试剂在室温可长期保持稳定，使得弈景^™系统有更加广泛的应用场景。

自该产品正式上市以来，Biocartis已在超过70个国家与地区销售用于指导肺癌、结直肠癌、黑色素瘤治疗的15个伴随诊断产品，覆盖包括EGFR、NRAS、KRAS、BRAF等基因中具有明确临床意义的检测位点，并有面向组织样本或液态活检应用的不同产品。

“不让生命等候”，万孚卡蒂斯将会持续改进及开发新的产品、与药厂进行伴随诊断研究合作，以满足中国市场的特定需求，提升诊断服务，为推进我国医学发展持续努力!

WondfoCartis is the wholly - owned subsidiary of the HK-based joint venture, which is funded by Guangzhou Wondfo Biotech Co., Ltd., a globally recognized fast growing POCT leader in China, and Biocartis Group NV, a leading Belgium biotechnology company in Europe.

The two sides jointly promote the introduction and commercial application of a fully automatic molecular diagnostic platform - Idylla™ （Mainland China trademark, easegene™）in cancer precision treatment in Mainland China. We are committed to providing accurate, sensitive and fast diagnosis for medicine guidance.

WondfoCartis is the pioneer in introducing the concept of fully automatic MDx in cancer precision treatment in China. easegene™, a fully automated, sample-to-result PCR-based molecular diagnostic system, provides same-day results. It takes less than 2 minutes’ hands-on-time and brings out the accurate and reliable result within around 2 hours.Based on its outstanding ease-of-use and pollution-proof design, easegene™ is a convenient device for the end-users and brings more benefit to patients. As easegene™ can be used with multiple biological sample types, it can be applied to detection various targets and provide reliable results. Reagents can remain stable for a long time at room temperature, extending the application range of easegene™.

Since Idylla™ was launched, Biocartis has sold 15 companion diagnostics products guiding the treatment of lung cancer, colorectal cancer, melanoma and etc. in more than 70 countries and regions. The detection panels with clinical significance include EGFR, NRAS, KRAS, BRAF and etc. It also covers various sample types including solid and liquid biopsies.

"Do Not Let Life Wait" is our core value of service. WondfoCartis will strive to make further improvement and development of new products and extensively cooperate with pharmaceutical factories in Companion Diagnostics research in order to meet the specific needs of the Chinese market, improve diagnostics services and boost the medical science in China.